PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC’s ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

Follow us on Twitter at @PTCBioLinkedIn and like us on Facebook at PTC Therapeutics Facebook.

Information and resources presented on this page were provided by our DuchenneXchange Industry sponsors.